Ashwin S Nathan, MD, MSHP
Assistant Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
Philadelphia, PA 19104
3400 Civic Center Boulevard
Philadelphia, PA 19104
Publications
Links
Search PubMed for articles
Giri-Nathan Cardiovascular Health Services and Policy Research Laboratory
Search PubMed for articles
Giri-Nathan Cardiovascular Health Services and Policy Research Laboratory
Education:
BSE (Bioengineering)
University of Pennsylvania, School of Engineering and Applied Science, 2009.
MD (Medicine)
Harvard Medical School, Department of Health Sciences and Technology, Boston MA, 2013.
MSHP (Science of Health Policy)
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 2020.
Permanent linkBSE (Bioengineering)
University of Pennsylvania, School of Engineering and Applied Science, 2009.
MD (Medicine)
Harvard Medical School, Department of Health Sciences and Technology, Boston MA, 2013.
MSHP (Science of Health Policy)
University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, 2020.
Selected Publications
Reddy KP, Nathan AS, Giri J.: Economics of Emerging Transcatheter Cardiovascular Interventions. JACC Cardiovasc Interv 18: 2169-2174, Sep 2025.Eberly LA, Shultz K, Kishore S, Hayden M, Turecamo S, Julien HM, Niklaus Davis E, Nathan A, Khatana SAM.: Cardiovascular Death and Access to Health Care Among Individuals Incarcerated in US State Prisons From 2001 to 2019. J Am Heart Assoc 14: e040983, Sep 2025.
Wu J, Kanter GP, Wagner TH, Chu D, Cashy JP, Prigge JM, Glorioso TJ, Rahman N, Murali N, Giri J, Nathan AS, Waldo SW, Groeneveld PW.: Impact of the MISSION Act on Quality and Outcomes of Major Cardiovascular Procedures Among Veterans. JAMA 334: 702-713, Aug 2025.
Nathan AS, Kennedy KF, Reddy KP, Fanaroff AC, Kolansky DM, Kobayashi TJ, Khatana SAM, Dayoub EJ, Eberly L, Rao SV, Mehran R, Bhatt D, Yeh RW, Spertus JA, Giri J.: Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals. J Am Heart Assoc 14: e038317, Mar 2025.
Reddy KP, Mehta S, Eberly LA, Khatana SAM, Chatterjee P, Fanaroff AC, Groeneveld PW, Giri J, Nathan AS.: Inter- and Intrahospital Price Variation for Common Cardiovascular Admission Diagnoses, Diagnostic Tests, and Therapeutic Procedures. J Am Heart Assoc 14: e038660, Mar 2025.
Shah T, Shah Y, Lansky AJ, Giri J, Fanaroff A, Nathan A.: Early Aortic Valve Replacement Versus Conservative Management: A Meta-Analysis of Randomized Controlled Trials. Struct Heart 9: 100461, Mar 2025.
Schwartz AW, Shah Y, Huang H, Nathan A, Fanaroff AC, Giri JS, Parikh SA, Lansky AJ, Shah T.: Corrigendum to "Comparison of the Safety and Efficacy of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-Analysis" (JSCAI, Volume 4, Issue 1, 2025, 102432). J Soc Cardiovasc Angiogr Interv 4: 102651, Mar 2025.
Shah T, Zhang Z, Shah H, Fanaroff AC, Nathan AS, Parise H, Lutz J, Sugeng L, Bellumkonda L, Redfors B, Omerovic E, Petrie MC, Vora AN, Fiorilli PN, Kobayashi T, Ahmad Y, Forrest JK, Giri JS, Herrmann HC, Lansky AJ.: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis. JACC Cardiovasc Interv 18: 738-748, Mar 2025.
Schwartz AW, Shah Y, Huang H, Nathan A, Fanaroff AC, Giri JS, Parikh SA, Lansky AJ, Shah T.: Comparison of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis. J Soc Cardiovasc Angiogr Interv 4: 102432, Jan 2025.
David G, Epstein AJ, Giri J, Nathan A, Chikermane SG, Ryan M, Thompson C, Clancy S, Gunnarsson C.: No-Transcatheter Aortic Valve Replacement (TAVR) Zones and Their Effect on Access to Care for Medicare Beneficiaries with Aortic Stenosis. Adv Ther 2025.
